Garcia-Alfonso, P.Reina Zoilo, J.Mata Velasco, E.Llanos, M.Illan Varella, A.Safont Aguilera, M.Delgado Urena, M.Castanon, C.Pimentel, P.Alonso Orduna, V.Mendez, J.Rivera Herrero, F.Siso, I.Rodriguez-Pascual, J.Gravalos Castro, C.Afonso, R.Fernandez Ranada, I.Grandez, R.Moreno, M.Munoz, A. LopezGarcia-Paredes, B.Aranda, E.2025-01-072025-01-072021-07-030923-7534https://hdl.handle.net/10668/25173enPrognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS studyconference outputopen access10.1016/j.annonc.2021.05.1051569-8041http://www.annalsofoncology.org/article/S0923753421012941/pdf670004200051